Stratos Wealth Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Buy
4,969
+994
+25% +$65.3K ﹤0.01% 1373
2026
Q1
$283K Sell
3,975
-228
-5% -$18K ﹤0.01% 1354
2025
Q4
$345K Sell
4,203
-279
-6% -$21.7K ﹤0.01% 1205
2025
Q3
$337K Sell
4,482
-78
-2% -$5.82K ﹤0.01% 1192
2025
Q2
$338K Buy
4,560
+103
+2% +$7.17K ﹤0.01% 1091
2025
Q1
$360K Sell
4,457
-619
-12% -$53.2K 0.01% 1013
2024
Q4
$397K Buy
5,076
+824
+19% +$70K 0.01% 1025
2024
Q3
$399K Sell
4,252
-1,327
-24% -$111K 0.01% 1017
2024
Q2
$435K Sell
5,579
-221
-4% -$18K 0.01% 956
2024
Q1
$527K Buy
5,800
+433
+8% +$36K 0.01% 874
2023
Q4
$415K Sell
5,367
-1,863
-26% -$130K 0.01% 942
2023
Q3
$492K Buy
7,230
+1,376
+24% +$100K 0.01% 825
2023
Q2
$476K Buy
5,854
+1,317
+29% +$105K 0.01% 782
2023
Q1
$372K Buy
+4,537
New +$324K 0.01% 791

Other funds holding GEHC

Stratos Wealth Partners's GEHC Position: Q2 2026 in Review

Stratos Wealth Partners increased its GE HealthCare (GEHC) stake by 25% in Q2 2026, buying an estimated $65.3K and bringing the position to 4,969 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Stratos Wealth Partners first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $527K in Q1 2024. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Stratos Wealth Partners held 4,969 shares of GE HealthCare worth $318K as of Q2 2026.
  • Stratos Wealth Partners bought 994 GE HealthCare shares in Q2 2026, an estimated $65.3K.
  • GE HealthCare made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #1373 holding.
  • Stratos Wealth Partners first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Stratos Wealth Partners's GE HealthCare position peaked at $527K in Q1 2024.
  • 1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.